BRIDGEBIO PHARMA INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BRIDGEBIO PHARMA INC NOTE 1.750% 3/0, CUSIP 10806XAJ1.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BRIDGEBIO PHARMA INC NOTE 1.750% 3/0, CUSIP 10806XAJ1.